Chen Y - Search Results

1

CircRTN4 promotes pancreatic cancer progression through a novel CircRNA-miRNA-lncRNA pathway and stabilizing epithelial-mesenchymal transition protein.

Wong CH, Lou UK, Fung FK, Tong JHM, Zhang CH, To KF, Chan SL, Chen Y. Wong CH, et al. Among authors: chen y. Mol Cancer. 2022 Jan 4;21(1):10. doi: 10.1186/s12943-021-01481-w. Mol Cancer. 2022. PMID: 34983537 Free PMC article.

2

Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus.

Ma Y, Yu J, Chan HL, Chen YC, Wang H, Chen Y, Chan CY, Go MY, Tsai SN, Ngai SM, To KF, Tong JH, He QY, Sung JJ, Kung HF, Cheng CH, He ML. Ma Y, et al. Among authors: chen yc, chen y. Mol Cell Proteomics. 2009 Nov;8(11):2582-94. doi: 10.1074/mcp.M900180-MCP200. Epub 2009 Aug 11. Mol Cell Proteomics. 2009. PMID: 19671925 Free PMC article.

3

Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A).

Lan FF, Wang H, Chen YC, Chan CY, Ng SS, Li K, Xie D, He ML, Lin MC, Kung HF. Lan FF, et al. Int J Cancer. 2011 Jan 15;128(2):319-31. doi: 10.1002/ijc.25336. Epub 2010 Mar 22. Int J Cancer. 2011. PMID: 20309945 Free article.

4

RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo.

Chen Y, Xie D, Yin Li W, Man Cheung C, Yao H, Chan CY, Chan CY, Xu FP, Liu YH, Sung JJ, Kung HF. Chen Y, et al. Cancer Lett. 2010 Nov 1;297(1):109-16. doi: 10.1016/j.canlet.2010.05.003. Epub 2010 Jun 1. Cancer Lett. 2010. PMID: 20684863

5

EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.

Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, Huang TH, Sung JJ. Cheng AS, et al. Among authors: chen y. Cancer Res. 2011 Jun 1;71(11):4028-39. doi: 10.1158/0008-5472.CAN-10-3342. Epub 2011 Apr 21. Cancer Res. 2011. PMID: 21512140

6

Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development.

Yip WK, Cheng AS, Zhu R, Lung RW, Tsang DP, Lau SS, Chen Y, Sung JG, Lai PB, Ng EK, Yu J, Wong N, To KF, Wong VW, Sung JJ, Chan HL. Yip WK, et al. Among authors: chen y. PLoS One. 2011;6(8):e22888. doi: 10.1371/journal.pone.0022888. Epub 2011 Aug 4. PLoS One. 2011. PMID: 21829663 Free PMC article.

7

Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.

Li CH, To KF, Tong JH, Xiao Z, Xia T, Lai PB, Chow SC, Zhu YX, Chan SL, Marquez VE, Chen Y. Li CH, et al. Among authors: chen y. Gastroenterology. 2013 May;144(5):1086-1097.e9. doi: 10.1053/j.gastro.2013.01.058. Epub 2013 Feb 7. Gastroenterology. 2013. PMID: 23395645

8

Targeting long non-coding RNAs in cancers: progress and prospects.

Li CH, Chen Y. Li CH, et al. Among authors: chen y. Int J Biochem Cell Biol. 2013 Aug;45(8):1895-910. doi: 10.1016/j.biocel.2013.05.030. Epub 2013 Jun 4. Int J Biochem Cell Biol. 2013. PMID: 23748105 Review.

9

Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.

Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, Chen Y. Li CH, et al. Among authors: chen y. Eur J Cancer. 2014 Oct;50(15):2560-9. doi: 10.1016/j.ejca.2014.07.008. Epub 2014 Jul 30. Eur J Cancer. 2014. PMID: 25087183

10

Novel therapeutic targets for pancreatic cancer.

Tang SC, Chen YC. Tang SC, et al. World J Gastroenterol. 2014 Aug 21;20(31):10825-44. doi: 10.3748/wjg.v20.i31.10825. World J Gastroenterol. 2014. PMID: 25152585 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165,866 results

Search Page